Delivery Order SPE2DB22D2103-SPE2DB24FR8SQ
- Not listed
- The federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The $9,371.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and was not set aside for a specific business type. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SYRINGES to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $18,253.52, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price pricing type and a completion date of May 22, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued...
- This federal contract award is for the delivery of Enbrel 50 mg/ml syringes to the Defense Logistics Agency (DLA). The $48,751.79 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a...
- This federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA). The contract, valued at $11,098.88, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENBREL 25 MG/0.5 ML SYRINGE 0.5ML. The firm-fixed-price delivery order, valued at $4,178.14, has a completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,158.68 Firm Fixed Price Delivery Order is for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,124.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle...
- This federal contract award is for the delivery of ENBREL 50 MG/ML syringes, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $42,452.84 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on August 23, 2024, with a completion date of August 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,176.65 delivery order contract is for the supply of ENBREL 50 MG/ML SYRINGE medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $99,348.69 firm fixed-price delivery order contract covers the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR8SQDelivery Order
This federal contract award is for the delivery of ENBREL 50 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $95,114.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have any set-aside designation, indicating it was competed on an open basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.1k | 1/3/24 |